Pathophysiology and Prevention of Neonatal Necrotizing Enterocolitis

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1169-1174

  Caplan, Michael S ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847261252     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50120-X     Document Type: Chapter

References (129)

1. Caplan MS, MacKendrick W Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 1993, 13:357-369.
2. Walsh MC, Kliegman RM Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986, 33:179-201.
3. Ballance WA, et al. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990, 117:S6-13.
4. Rodin AE, et al. Necrotizing enterocolitis occurring in full-term neonates at birth. Arch Pathol 1973, 96:335-338.
5. Wiswell TE, et al. Necrotizing enterocolitis in full-term infants: a case-control study. Am J Dis Child 1988, 142:532-535.
6. Martinez-Tallo E, et al. Necrotizing enterocolitis in full-term or near-term infants: risk factors. Biol Neonate 1997, 71:292-298.
7. Bolisetty S, Lui K Necrotizing enterocolitis in full-term neonates. J Paediatr Child Health 2001, 37:413-414.
8. Lopez SL, et al. Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure. Clin Pediatr 1995, 34:424-429.
9. Uauy RD, et al. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991, 119:630-638.
10. Ryder RW, et al. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980, 112:113-123.
11. Lucas A, Cole TJ Breast milk and neonatal necrotising enterocolitis. Lancet 1990, 336:1519-1523.
12. Furlano RI, Walker WA Immaturity of gastrointestinal host defense in newborns and gastrointestinal disease states. Adv Pediatr 1998, 45:201-222.
13. Bines JE, Walker WA Growth factors and the development of neonatal host defense. Adv Exp Med Biol 1991, 310:31-39.
14. Walker WA Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr 2000, 30:S2-S7.
15. Berseth CL Gestational evolution of small intestine motility in preterm and term infants. J Pediatr 1989, 115:646-651.
16. Berseth CL Neonatal small intestinal motility: motor responses to feeding in term and preterm infants. J Pediatr 1990, 117:777-782.
17. Berseth CL Gut motility and the pathogenesis of necrotizing enterocolitis. Clin Perinatol 1994, 21:263-270.
18. Bueno L, Ruckebusch Y Perinatal development of intestinal myoelectrical activity in dogs and sheep. Am J Physiol 1979, 237:E61-E67.
19. Caplan MS, et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999, 117:577-583.
20. Caplan MS, et al. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol 1994, 14:1017-1028.
21. Deitch EA Role of bacterial translocation in necrotizing enterocolitis. Acta Paediatr Suppl 1994, 396:33-36.
22. Duffy LC, et al. Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis. Dig Dis Sci 1997, 42:359-365.
23. Duffy LC, et al. Bacterial toxins and enteral feeding of premature infants at risk for necrotizing enterocolitis. Adv Exp Med Biol 2001, 501:519-527.
24. Nowicki PT, Miller CE Autoregulation in the developing postnatal intestinal circulation. Am J Physiol 1988, 254:G189-G193.
25. Nowicki PT, et al. Effects of ischemia and reperfusion on intrinsic vascular regulation in the postnatal intestinal circulation. Pediatr Res 1993, 33:400-404.
26. Nowicki PT Effects of sustained flow reduction on postnatal intestinal circulation. Am J Physiol 1998, 275:G758-G768.
27. Dvorak B, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol 2002, 282:G156-G164.
28. Caplan M, et al. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990, 39:705-714.
29. Nanthakumar NN, et al. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A 2000, 97:6043-6048.
30. Haller D, et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000, 47:79-87.
31. Kagnoff MF Immunology of the intestinal tract. Gastroenterology 1993, 105:1275-1280.
32. Laboisse CL Structure of gastrointestinal mucins: searching for the Rosetta stone. Biochimie 1986, 68:611-617.
33. Pang KY, et al. Development of the gastrointestinal mucosal barrier. V. Comparative effect of calcium binding on microvillus membrane structure in newborn and adult rats. Pediatr Res 1983, 17:856-861.
34. Pang KY, et al. Development of the gastrointestinal mucosal barrier: evidence for structural differences in microvillus membranes from newborn and adult rabbits. Biochim Biophys Acta 1983, 727:201-208.
35. Pang KY, et al. Development of gastrointestinal mucosal barrier. VII. In utero maturation of microvillus surface by cortisone. Am J Physiol 1985, 249:G85-G91.
36. Udall JN, et al. Development of gastrointestinal mucosal barrier. I. The effect of age on intestinal permeability to macromolecules. Pediatr Res 1981, 15:241-244.
37. Udall JN Gastrointestinal host defense and necrotizing enterocolitis. J Pediatr 1990, 117:S33-S43.
38. Hsueh W, et al. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr Suppl 1994, 396:11-17.
39. Weaver LT, Laker MF, Nelson R Intestinal permeability in the newborn. Arch Dis Child 1984, 59:236-241.
40. Smith SD, et al. Unique characteristics of the neonatal intestinal mucosal barrier. J Pediatr Surg 1992, 27:333-336.
41. Snyder JD, Walker WA Structure and function of intestinal mucin: developmental aspects. Int Arch Allergy Appl Immunol 1987, 82:351-356.
42. Lin J, et al. Expression of intestinal trefoil factor in developing rat intestine. Biol Neonate 1999, 76:92-97.
43. Sands BE, Podolsky DK The trefoil peptide family. Annu Rev Physiol 1996, 58:253-273.
44. Tan XD, et al. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 1997, 237:673-677.
45. Salzman NH, et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998, 44:20-26.
46. Ouellette AJ Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 1997, 113:1779-1784.
47. Guy-Grand D, et al. The mouse gut T lymphocyte, a novel type of T cell: nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med 1978, 148:1661-1677.
48. Rieger CH, Rothberg RM Development of the capacity to produce specific antibody to an ingested food antigen in the premature infant. J Pediatr 1975, 87:515-518.
49. Perkkio M, Savilahti E Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res 1980, 14:953-955.
50. Roberts SA, Freed DL Neonatal IgA secretion enhanced by breast feeding. Lancet 1977, 2:1131.
51. Eibl MM, et al. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 1988, 319:1-7.
52. Villalpando S, Hamosh M Early and late effects of breast-feeding: does breast-feeding really matter?. Biol Neonate 1998, 74:177-191.
53. Wold AE, Adlerberth I Breast feeding and the intestinal microflora of the infant: implications for protection against infectious diseases. Adv Exp Med Biol 2000, 478:77-93.
54. Lee WJ, et al. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 1998, 66:1421-1426.
55. Neu J, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 1997, 131:691-699.
56. Neu J, et al. Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 2002, 5:69-75.
57. Neurath MF, et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996, 183:2605-2616.
58. Riegler M, et al. Effect of growth factors on epithelial restitution of human colonic mucosa in vitro. Scand J Gastroenterol 1997, 32:925-932.
59. Juul SE, et al. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999, 46:263-268.
60. Ledbetter DJ, Juul SE Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 2000, 35:178-181.
61. Dai D, et al. Role of oligosaccharides and glycoconjugates in intestinal host defense. J Pediatr Gastroenterol Nutr 2000, 30:S23-S33.
62. Caplan MS, et al. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res 2001, 49:647-652.
63. Carlson SE, et al. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr Res 1998, 44:491-498.
64. Tanaka M, et al. Exogenous nucleotides alter the proliferation, differentiation and apoptosis of human small intestinal epithelium. J Nutr 1996, 126:424-433.
65. Bisset WM, et al. Ontogeny of fasting small intestinal motor activity in the human infant. Gut 1988, 29:483-488.
66. Lawrence G, et al. Pathogenesis of neonatal necrotising enterocolitis. Lancet 1982, 1:137-139.
67. Peter CS, et al. Necrotising enterocolitis: is there a relationship to specific pathogens?. Eur J Pediatr 1999, 158:67-70.
68. Tomkins AM, et al. Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban U.K. J Hyg (Lond) 1981, 86:285-293.
69. Rubaltelli FF, et al. Intestinal flora in breast- and bottle-fed infants. J Perinat Med 1998, 26:186-191.
70. Gewolb IH, et al. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999, 80:F167-F173.
71. Yoshimura A, et al. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999, 163:1-5.
72. Deitch EA, et al. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991, 19:785-791.
73. Birchler T, et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001, 31:3131-3137.
74. Panigrahi P, et al. Occurrence of necrotizing enterocolitis may be dependent on patterns of bacterial adherence and intestinal colonization: studies in Caco-2 tissue culture and weanling rabbit models. Pediatr Res 1994, 36:115-121.
75. Hoyos AB Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999, 3:197-202.
76. Alward CT, et al. Effects of asphyxia on cardiac output and organ blood flow in the newborn piglet. Pediatr Res 1978, 12:824-827.
77. Touloukian RJ, et al. The pathogenesis of ischemic gastroenterocolitis of the neonate: selective gut mucosal ischemia in asphyxiated neonatal piglets. J Pediatr Surg 1972, 7:194-205.
78. Schoenberg MH, Beger HG Reperfusion injury after intestinal ischemia. Crit Care Med 1993, 21:1376-1386.
79. Crissinger KD Animal models of necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1995, 20:17-22.
80. Nankervis CA, Nowicki PT Role of endothelin-1 in regulation of the postnatal intestinal circulation. Am J Physiol 2000, 278:G367-G375.
81. Nankervis CA, Nowicki PT Role of nitric oxide in regulation of vascular resistance in postnatal intestine. Am J Physiol 1995, 268:G949-G958.
82. Nowicki PT, et al. Intestinal blood flow and O2 uptake during hypoxemia in the newborn piglet. Am J Physiol 1986, 251:G19-G24.
83. Nowicki PT, Minnich LA Effects of systemic hypotension on postnatal intestinal circulation: role of angiotensin. Am J Physiol 1999, 276:G341-G352.
84. Reber KM, et al. Newborn intestinal circulation: physiology and pathophysiology. Clin Perinatol 2002, 29:23-39.
85. Nankervis CA, et al. Age-dependent changes in the postnatal intestinal microcirculation. Microcirculation 2001, 8:377-387.
86. Brown EG, Sweet AY Preventing necrotizing enterocolitis in neonates. JAMA 1978, 240:2452-2454.
87. Stoll BJ, et al. Epidemiology of necrotizing enterocolitis: a case control study. J Pediatr 1980, 96:447-451.
88. Kamitsuka MD, et al. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics 2000, 105:379-384.
89. Tyson JE, Kennedy KA Minimal enteral nutrition for promoting feeding tolerance and preventing morbidity in parenterally fed infants. Cochrane Database Syst Rev 2000, 2.
90. Di Lorenzo M, et al. An intraluminal model of necrotizing enterocolitis in the developing neonatal piglet. J Pediatr Surg 1995, 30:1138-1142.
91. Caplan MS, et al. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 1997, 42:779-783.
92. Pitt J, et al. Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes. Pediatr Res 1977, 11:906-909.
93. Kliegman RM, et al. Necrotizing enterocolitis in neonates fed human milk. J Pediatr 1979, 95:450-453.
94. Willis DM, et al. Unsuspected hyperosmolality of oral solutions contributing to necrotizing enterocolitis in very-low-birth-weight infants. Pediatrics 1977, 60:535-538.
95. White KC, Harkavy KL Hypertonic formula resulting from added oral medications. Am J Dis Child 1982, 136:931-933.
96. Butel MJ, et al. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 1998, 47:391-399.
97. Clark DA, et al. Necrotizing enterocolitis: intraluminal biochemistry in human neonates and a rabbit model. Pediatr Res 1985, 19:919-921.
98. Clark DA, Miller MJ Intraluminal pathogenesis of necrotizing enterocolitis. J Pediatr 1990, 117:S64-S67.
99. Dunn L, et al. Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: preliminary report of a randomized trial. J Pediatr 1988, 112:622-629.
100. Slagle TA, Gross SJ Effect of early low-volume enteral substrate on subsequent feeding tolerance in very low birth weight infants. J Pediatr 1988, 113:526-531.
101. Schanler RJ, et al. Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics 1999, 103:434-439.
102. Troche B, et al. Early minimal feedings promote growth in critically ill premature infants. Biol Neonate 1995, 67:172-181.
103. Caplan MS, MacKendrick W Inflammatory mediators and intestinal injury. Clin Perinatol 1994, 21:235-246.
104. Caplan MS, Jilling T New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001, 13:111-115.
105. O'Neill LA The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2000, 2000:RE1-RE9.
106. Medzhitov R Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
107. Read RC, Wyllie DH Toll receptors and sepsis. Curr Opin Crit Care 2001, 7:371-375.
108. Tracey KJ, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986, 234:470-474.
109. Benveniste J PAF-acether, an ether phospho-lipid with biological activity. Prog Clin Biol Res 1988, 282:73-85.
110. Hsueh W, et al. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor: a mechanistic study of platelet-activating factor-induced bowel necrosis. Gastroenterology 1988, 94:1412-1418.
111. Hsueh W, et al. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. J Clin Invest 1986, 78:108-114.
112. Cueva JP, Hsueh W Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut 1988, 29:1207-1212.
113. Ford H, et al. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997, 32:275-282.
114. Hammerman C, et al. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Pediatr Gastroenterol Nutr 1999, 29:69-74.
115. Wallace JL, et al. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol 1995, 280:63-68.
116. Tan X, et al. PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta 1994, 1215:157-162.
117. Sun X, et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol 1997, 273.
118. Takakuwa T, et al. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome. Res Commun Mol Pathol Pharmacol 1997, 98:43-52.
119. Caplan MS, et al. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr 1997, 24:296-301.
120. Caplan MS, et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990, 116:960-964.
121. Caplan MS, et al. Hypoxia, PAF, and necrotizing enterocolitis. Lipids 1991, 26:1340-1343.
122. Hsueh W, et al. Platelet-activating factor-induced ischemic bowel necrosis: an investigation of secondary mediators in its pathogenesis. Am J Pathol 1986, 122:231-239.
123. Gonzalez-Crussi F, Hsueh W Experimental model of ischemic bowel necrosis: the role of platelet-activating factor and endotoxin. Am J Pathol 1983, 112:127-135.
124. Rabinowitz SS, et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 2001, 138:81-86.
125. Mozes T, et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 1989, 257:872-877.
126. Sun XM, Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988, 81:1328-1331.
127. Caplan MS, et al. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology 1990, 99:979-986.
128. Edelson MB, et al. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999, 103:766-771.
129. Lindsay JO, et al. The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol 2001, 166:7625-7633.